ImmunityBio, Inc.IBRXNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-3.40%
↑ 52% vs avg
Percentile
P44
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-7.02%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -3.40% |
| Q3 2025 | 14.75% |
| Q2 2025 | 7.12% |
| Q1 2025 | 0.26% |
| Q4 2024 | 14.08% |
| Q3 2024 | -0.48% |
| Q2 2024 | 6.63% |
| Q1 2024 | 12.16% |
| Q4 2023 | -32.39% |
| Q3 2023 | -5.41% |
| Q2 2023 | 4.79% |
| Q1 2023 | 15.43% |
| Q4 2022 | -13.59% |
| Q3 2022 | 9.95% |
| Q2 2022 | -4.81% |
| Q1 2022 | -24.66% |
| Q4 2021 | -1.60% |
| Q3 2021 | -4.00% |
| Q2 2021 | -14.93% |
| Q1 2021 | -18.71% |
| Q4 2020 | -45.78% |
| Q3 2020 | 15.20% |
| Q2 2020 | -46.49% |
| Q1 2020 | -101.88% |
| Q4 2019 | 8.36% |
| Q3 2019 | 4.64% |
| Q2 2019 | -17.32% |
| Q1 2019 | 5.57% |
| Q4 2018 | 24.28% |
| Q3 2018 | -13.20% |
| Q2 2018 | 8.11% |
| Q1 2018 | 18.59% |
| Q4 2017 | -20.25% |
| Q3 2017 | 9.76% |
| Q2 2017 | -58.63% |
| Q1 2017 | -20.27% |
| Q4 2016 | 12.00% |
| Q3 2016 | -47.08% |
| Q2 2016 | 5.70% |
| Q1 2016 | 16.61% |